Anti-angiogenic therapy: adapting strategies to overcome resistant tumors

Journal of Cellular Biochemistry
Dianne C Mitchell, Brad A Bryan

Abstract

Healthy cells, as well as benign and malignant tumors, depend upon the body's blood supply to bring in oxygen and nutrients and carry away waste products. Using this property against tumors, anti-angiogenic therapy targets the tumor vasculature with the aim of starving the tumor, and has demonstrated exceptional clinical efficacy against a number of tumors. This review discusses the current state of knowledge regarding anti-angiogenic therapies presently available to patients, and garners from both preclinical and clinical literature the benefits and side effects associated with anti-angiogenic therapies, the unfortunate mechanisms of acquired resistance to these novel therapeutics, and highlights promising next generation anti-angiogenics that may overcome the limitations encountered with first generation therapies.

References

Feb 1, 1971·The Journal of Experimental Medicine·J FolkmanG Williams
Mar 21, 1998·The Journal of Cell Biology·S EsserW Risau
Dec 6, 2000·The Journal of Clinical Investigation·Y KasaharaN F Voelkel
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·C J KuoR C Mulligan
Mar 14, 2002·The American Journal of Pathology·Shunichi MorikawaDonald M McDonald
Nov 14, 2002·British Journal of Pharmacology·David S GélinasMartin G Sirois
Feb 28, 2003·European Journal of Haematology·Jirí PomyjeEmanuel Necas
Apr 4, 2003·Advances in Experimental Medicine and Biology·Eberhard Gunsilius
Apr 24, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Benedetta BussolatiGiovanni Camussi
May 16, 2003·Vascular Pharmacology·D O Bates, S J Harper
Jun 20, 2003·Current Biology : CB·Eckhard LammertDouglas A Melton
Jul 19, 2003·Neoplasia : an International Journal for Oncology Research·Jennifer R Allport, Ralph Weissleder
Feb 28, 2004·Liver International : Official Journal of the International Association for the Study of the Liver·Hiroaki YokomoriHiromasa Ishii
Jun 10, 2004·American Journal of Physiology. Renal Physiology·Takahiko NakagawaRichard J Johnson
Jul 16, 2004·The New England Journal of Medicine·Berthold StreubelIlse Schwarzinger
Sep 11, 2004·Blood·Jose R Conejo-GarciaGeorge Coukos
Dec 21, 2004·Angiogenesis·David C SaneK Bridget Brosnihan
Mar 12, 2005·International Journal of Cancer. Journal International Du Cancer·Balázs DömeJózsef Tímár
Jun 23, 2005·Cell Cycle·Kenneth K W ToL Eric Huang
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerBrian I Rini
Jan 27, 2006·The American Journal of Pathology·Arindel S R MaharajPatricia A D'Amore
Nov 7, 2006·Bone·Gilles BluteauJérôme Guicheux
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jan 30, 2007·Endocrine-related Cancer·Shalini Patiar, Adrian L Harris
Jan 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xiaolei ZhuChirag R Parikh
Feb 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annalisa PezzoloVito Pistoia
Feb 10, 2007·International Journal of Cancer. Journal International Du Cancer·Shereen KelegJörg Kleeff
Feb 13, 2007·Nature Structural & Molecular Biology·Claudia RuchKurt Ballmer-Hofer
Feb 20, 2007·Cancer Letters·Shiwu ZhangBaocun Sun
May 29, 2007·Microvascular Research·Arindel S R Maharaj, Patricia A D'Amore
Sep 28, 2007·Current Pharmaceutical Design·Georgios KesisisGiuseppe Giaccone

❮ Previous
Next ❯

Citations

Mar 30, 2011·Expert Opinion on Investigational Drugs·Liu HongDaiming Fan
Feb 21, 2013·Experimental Cell Research·Chenghua Gu, Enrico Giraudo
Dec 4, 2012·Journal of Internal Medicine·G SeriniE Giraudo
Oct 27, 2011·BMB Reports·Meejung Kim, Senyon Choe
Jan 26, 2020·International Journal of Molecular Sciences·Suyash SrivastavaConstantinos M Mikelis
Apr 4, 2021·Cancers·Fatema Tuz ZahraConstantinos M Mikelis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.